The Connection Between
Patient Trust in AID Systems and Improved Diabetes Management Among People with T1D
What's the Story?
Automated insulin delivery (AID) systems have become common care components for individuals with Type 1 diabetes (T1). Yet since AID systems are relatively new, there remain underexplored questions of how much patients trust them.
This study examines how patient trust in AID systems correlates with the perceived effectiveness of the system and how they alleviate diabetes management burdens.
Study Findings
- Review habits as a proxy for trust: Respondents were split between passive and active reviewers based on how frequently they verified their AID system’s response to blood glucose changes.
- Glycemic control by reviewer type: Compared to active reviewers, a higher percentage of passive reviewers had an HbA1c greater than the clinical recommendation of 7.0%.
- AID system algorithm ratings by reviewer type: Passive reviewers were more likely to rate their AID system’s algorithm as optimal compared to active reviewers. Correspondingly, active reviewers were more likely to review their algorithm as either too aggressive or too conservative compared to passive reviewers.
- Perceived cognitive benefits and satisfaction with diabetes management by reviewer type: Passive reviewers also reported experiencing fewer diabetes-related disruptions, greater reductions in the effort required for their diabetes management and improved sleep, as well as greater overall satisfaction with their diabetes management while using their AID system.
Download the Poster
Download the poster, including additional data showing cognitive benefits of AID systems and satisfaction with diabetes management while using an AID system.
Suggested Articles
dQ&A presented three research abstracts at ATTD 2025, an academic and professional conference of innovation and advancement in diabetes devices.
Read More
Do You Have Questions
About Diabetes Research?
This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.
